Whey protein hydrolysates – nutrition for hospital patients
The whey protein hydrolysates in the Arla Foods Ingredients portfolio include mild to extensively hydrolysed whey proteins that support health in various ways. Enteral nutrition formulas are among the application possibilities.
Our hydrolysed products are enzymatically treated for the fastest possible absorption in the human body.
Whey protein hydrolysates may improve nutritional status and gut and liver functions in specific patient groups and can help prevent loss of lean body mass during hospitalisation, shortening hospital stays. For patients who depend on enteral feeding products, maintenance of body mass is particularly key.
Whey protein hydrolysates may also improve blood glucose control in people with metabolic syndrome or type 2 diabetes. This is due to a superior insulinotropic effect compared to intact proteins.
- Lacprodan® DI-3071: UHT stable whey protein hydrolysate for neutral beverages with a low bitterness profile and high solubility. DH (6-10) and 80% protein concentrate approx. dry matter
- Lacprodan® DI-3065: UHT stable whey protein hydrolysate with a low bitterness profile suitable for high protein clear beverages over a wide pH range DH (23-29) and 81% protein concentrate approx. dry matter
- Lacprodan® DI-2021: casein protein hydrolysate containing high amounts of casein phoapho peptides (CPP) DH (8) and 93% protein concentrate approx. dry matter